| Clonal hematopoiesis in patients with HIV and cancer N Gillis, BL Dickey, C Colin-Leitzinger, YH Tang, RM Putney, TE Mesa, ... The Journal of Infectious Diseases, jiae212, 2024 | | 2024 |
| BATCH-FLEX: Feature-level equalization of x-batch in heterogeneous cancer data J Davis, A Obermayer, T Duong, R Hesterberg, X Wang, M Teng, ... Cancer Research 84 (6_Supplement), 7423-7423, 2024 | | 2024 |
| FDA approved library screen revealed Ewing and clear cell sarcomas have increased sensitivity to filanesib over other cancer types HL Walker-Mimms, N Londono, Y Liao, N Chaudhary, DP Gomez, ... Cancer Research 84 (6_Supplement), 647-647, 2024 | | 2024 |
| An Epigenomic fingerprint of human cancers by landscape interrogation of super enhancers at the constituent level X Liu, N Gillis, C Jiang, A McCofie, TI Shaw, AC Tan, B Zhao, L Wan, ... PLOS Computational Biology 20 (2), e1011873, 2024 | | 2024 |
| Identification of Cancer-specific Constituent Elements inside Super-enhancers (cSEAdb) X Liu, N Gillis, C Jiang, A McCofie, TI Shaw, AC Tan, B Zhao, L Wan, ... | | 2024 |
| The DNA loop release factor WAPL suppresses Epstein-Barr virus latent membrane protein expression to maintain the highly restricted latency I program L Murray-Nerger, D Maestri, X Liu, Z Li, I Tempera, M Teng, BE Gewurz bioRxiv, 2024.05. 09.593401, 2024 | | 2024 |
| Differences in epigenetic age by HIV status among patients with a non-AIDS defining cancer BL Dickey, RM Putney, G Suneja, JK Kresovich, AM Spivak, AB Patel, ... AIDS 37 (13), 2049-2057, 2023 | 1 | 2023 |
| Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National Registry N Gillis, E Padron, T Wang, K Chen, JD DeVos, SR Spellman, SJ Lee, ... Transplantation and Cellular Therapy 29 (10), 640. e1-640. e8, 2023 | 1 | 2023 |
| Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study J Mammadova, C Colin-Leitzinger, D Nguyen, R Mhaskar, S Ganesan, ... JCO Precision Oncology 7, e2300208, 2023 | 1 | 2023 |
| PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing AN Obermayer, D Chang, G Nobles, M Teng, AC Tan, X Wang, YA Chen, ... BMC bioinformatics 24 (1), 266, 2023 | 1 | 2023 |
| A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth C Wang, X Liu, J Liang, Y Narita, W Ding, D Li, L Zhang, H Wang, ... Nature communications 14 (1), 1598, 2023 | 6 | 2023 |
| Statistical Analysis in ChIP-seq-Related Applications M Teng Statistical Genomics, 169-181, 2023 | | 2023 |
| An autochthonous model of lung cancer in the Naked Mole-Rat (Heterocephalus glaber) J Kissil, A Shepard, S Troutman, S Hoxha, D Lester, W Khaled, ESJ Smith, ... bioRxiv, 2023.08. 28.555115, 2023 | | 2023 |
| The Epstein-Barr virus enhancer interaction landscapes in virus-associated cancer cell lines W Ding, C Wang, Y Narita, H Wang, MML Leong, A Huang, Y Liao, X Liu, ... Journal of virology 96 (18), e00739-22, 2022 | 9 | 2022 |
| A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer C Jiang, NP Ward, N Prieto-Farigua, YP Kang, A Thalakola, M Teng, ... Redox Biology 54, 102358, 2022 | 7 | 2022 |
| Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma LC Peres, CM Colin-Leitzinger, M Teng, J Dutil, RR Alugubelli, G DeAvila, ... Blood Advances 6 (12), 3767-3778, 2022 | 15 | 2022 |
| DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression (vol 5, pg 1051, 2020) R Guo, Y Zhang, M Teng, C Jiang, M Schineller, B Zhao, JG Doench, ... NATURE MICROBIOLOGY 7 (6), 928-928, 2022 | | 2022 |
| Summarizing internal dynamics boosts differential analysis and functional interpretation of super enhancers X Liu, B Zhao, TI Shaw, BL Fridley, DR Duckett, AC Tan, M Teng Nucleic Acids Research 50 (6), 3115-3127, 2022 | 4 | 2022 |
| Unique ER PR expression pattern in breast cancers with CHEK2 mutation: a hormone receptor and HER2 analysis based on germline cancer predisposition genes G Wei, M Teng, M Rosa, X Wang Breast Cancer Research 24 (1), 11, 2022 | 4 | 2022 |
| DRPPM-EASY: A Web-Based Framework for Integrative Analysis of Multi-Omics Cancer Datasets A Obermayer, L Dong, Q Hu, M Golden, JD Noble, P Rodriguez, ... Biology 11 (2), 260, 2022 | 5 | 2022 |
